<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01842932</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-MED-CT4-09-257</org_study_id>
    <nct_id>NCT01842932</nct_id>
  </id_info>
  <brief_title>Usefulness Of Flospan As A Premedication For Colonoscopy</brief_title>
  <official_title>Usefulness Of Flospan As A Premedication For Colonoscopy : A Randomized Double Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Usefulness of Flospan as a premedication for colonoscopy: A randomized double-blind
      controlled trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cimetropium bromide is premedication of colonoscopy. However, it is contraindication for some
      diseases; benign prostatic hyperplasia(BPH) or other obstructive uropathy, intestinal
      obstruction, pyloric stenosis, glaucoma, myasthenia gravis, megacolon, paralytic ileus. In
      this cases, Flospan (phloroglucin) is effective alternative drug. So our research was to
      compare the effects of these two drugs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non inferiority of phloroglucin to cimetropium bromide</measure>
    <time_frame>Up to ten months</time_frame>
    <description>Comparing the two groups of time of examination, frequency of peristalsis, Scoring for the experimenter and the subject of the inspection feedback, double-blind setting.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total diagnostic colonoscopy exam time</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of practitioners</measure>
    <time_frame>1 year</time_frame>
    <description>Colonic motility and test difficulty</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of subjects</measure>
    <time_frame>1 year</time_frame>
    <description>The degree of discomfort after test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peristalsis time of transverse colon</measure>
    <time_frame>1 year</time_frame>
    <description>Total peristalsis time of transverse colon for two minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose and times of sedatives for pain control</measure>
    <time_frame>1 year</time_frame>
    <description>Total dose and times of sedatives (midazolam, propofol) for pain control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of cecal intubation</measure>
    <time_frame>1 year</time_frame>
    <description>Total time of colonoscope intubation from anus to cecum</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Bowel cleansing status</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Heart rate, respiratory rate, oxygen saturation, blood pressure</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phloroglucin 20ml before examination &amp; Placebo 1ml before examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cimetropium bromide 1ml before examination &amp; Placebo 20ml before examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phloroglucin</intervention_name>
    <description>Premedication of colonoscopy</description>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <other_name>Flospan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cimetropium bromide</intervention_name>
    <description>Premedication of colonoscopy</description>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <other_name>Anticholinergics</other_name>
    <other_name>Algiron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Diagnostic examination of colon</description>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <other_name>Diagnostic examination of colon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for double-blind study These are harmless to the human body, and are composed of saline solution without drug efficacy.</description>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recipient endoscopic diagnostic purposes.

        Exclusion Criteria:

          -  If you currently pregnant, or of childbearing potential

          -  Previous abdominal surgery or bowel resection.

          -  If under 18 years of age

          -  If the last two days, the administration of anticholinergic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kee Myung Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kee Myung Lee, M.D., Ph.D.</last_name>
    <phone>82-31-219-6939</phone>
    <email>lkm5104@ajou.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sun Gyo Lim, M.D.</last_name>
    <phone>82-31-219-6939</phone>
    <email>mdlsk75@hanmail.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <zip>443-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kee Myung Lee, M.D., Ph.D.</last_name>
      <phone>82-31-219-6939</phone>
      <email>lkm5104@ajou.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Sun Gyo Lim, M.D.</last_name>
      <phone>82-31-219-6939</phone>
      <email>mdlsk75@hanmail.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2013</study_first_submitted>
  <study_first_submitted_qc>April 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2013</study_first_posted>
  <last_update_submitted>June 25, 2014</last_update_submitted>
  <last_update_submitted_qc>June 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Sun Gyo Lim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Anticholinergics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Cholinergic Antagonists</mesh_term>
    <mesh_term>Cimetropium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

